Boston Scientific Delivers Q2 Beat with $5.44B Revenue, Cuts 2026 Guidance

SentiSense · Published · Updated

Boston Scientific reported Q2 revenue of $5.44 billion, beating estimates. The company adjusted EPS was $0.86, $0.03 ahead of expectations. Boston Sci...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis